Corfield A P, Clamp J R, Wagner S A
Biochem J. 1985 Feb 15;226(1):163-74. doi: 10.1042/bj2260163.
The activities of ten enzymes involved in sialic acid metabolism were measured in colonic mucosal cells from rats and compared with those in liver. A methodology was devised that enabled all ten enzyme activities to be evaluated in a single rat colon preparation. Enzyme assays with radioactively labelled substrates were developed for maximum sensitivity, and the identification of substrates and products was carefully checked to assess the contribution of contaminants to enzyme reactions with low activity. The activities of most enzymes involved in the biosynthesis of N-acetyl-D-neuraminic acid (NeuAc) from UDP-N-acetyl-D-glucosamine were found to be more than 20-fold lower than those in liver. The activities of CMP-NeuAc synthase, N-acetyl-D-glucosamine 2-epimerase, N-acetyl-D-glucosamine kinase, sialyltransferase and sialidase were similar to or 2-4-fold lower than in liver. The biosynthesis of NeuAc via its 9-phosphate was demonstrated in the 100 000 g supernatant of colonic-cell homogenates by enzymic assay and precursor experiments with N-acetyl[14C]-mannosamine. No alternative route for NeuAc formation could be detected. The 100 000g supernatant fractions of liver, kidney and colonic mucosal cells utilized N-acetyl[14C]mannosamine with differing efficiencies. Radioactive products identified as sialic acid biosynthetic intermediates amounted to 49%, 0.04% and 5.6% of added precursor in liver, kidney and colon respectively. Catabolism of labelled precursor to non-hexosamine products was high in kidney and colonic mucosal-cell fractions.
在大鼠结肠黏膜细胞中测定了参与唾液酸代谢的十种酶的活性,并与肝脏中的酶活性进行了比较。设计了一种方法,能够在一份大鼠结肠标本中评估所有十种酶的活性。开发了使用放射性标记底物的酶分析方法以实现最大灵敏度,并仔细检查底物和产物的鉴定,以评估污染物对低活性酶反应的贡献。发现从UDP-N-乙酰-D-葡萄糖胺生物合成N-乙酰-D-神经氨酸(NeuAc)的大多数酶的活性比肝脏中的活性低20倍以上。CMP-NeuAc合酶、N-乙酰-D-葡萄糖胺2-差向异构酶、N-乙酰-D-葡萄糖胺激酶、唾液酸转移酶和唾液酸酶的活性与肝脏中的相似或比肝脏中的低2-4倍。通过酶分析和使用N-乙酰[14C]-甘露糖胺的前体实验,在结肠细胞匀浆的100000g上清液中证实了通过其9-磷酸合成NeuAc的过程。未检测到NeuAc形成的替代途径。肝脏、肾脏和结肠黏膜细胞的100000g上清液部分利用N-乙酰[14C]甘露糖胺的效率不同。在肝脏、肾脏和结肠中,鉴定为唾液酸生物合成中间体的放射性产物分别占添加前体的49%、0.04%和5.6%。在肾脏和结肠黏膜细胞部分中,标记前体分解代谢为非己糖胺产物的比例很高。